VS
stockvs
Go to ScreenerHub
LLY

LLY vs NVS

NVS

In the past 12 months, NVS returned +38% while LLY gained 20%.

LLY
LLY

Eli Lilly and Company

$988.79
-4.6%(1M)
Market Cap934.2B
Healthcare
Drug Manufacturers - General
USA
P/E Ratio43.57
ROE97.9%
P/B Ratio33.89
Dividend Yield0.6%
NVS
NVS

Novartis AG

$154.87
-6.8%(1M)
Market Cap299.4B
Healthcare
Drug Manufacturers - General
CH
P/E Ratio21.34
ROE32.8%
P/B Ratio6.48
Dividend Yield3.0%
Performance Comparison

Historical returns across multiple timeframes

LLY leads 5/8
LLY

LLY

Eli Lilly and Company

+19.9%

1Y Return

NVS

NVS

Novartis AG

+38.0%

1Y Return

LLY
LLY
NVS
NVS

Short Term

1M-6M

NVS
+11.3%

Medium Term

YTD-1Y

NVS
+24.9%

Long Term

3Y-10Y

LLY
+627.4%

Valuation

Compare price multiples and valuation ratios

LLY: 0NVS: 5
MetricLLYNVSWinner
P/E Ratio

Price to earnings ratio

43.5721.34NVS
Forward P/E

Forward price to earnings ratio

0.000.00Tie
P/S Ratio

Price to sales ratio

14.495.30NVS
P/B Ratio

Price to book ratio

33.896.48NVS
P/FCF Ratio

Price to free cash flow ratio

105.2917.78NVS
EV/EBITDA

Enterprise value to EBITDA

34.9814.15NVS
PEG Ratio

Price/earnings to growth ratio

0.000.00Tie

Profitability

Compare profit margins and returns on capital

LLY: 6NVS: 0
MetricLLYNVSWinner
Gross Margin

Gross profit margin

83.8%75.7%LLY
Operating Margin

Operating profit margin

45.6%31.2%LLY
Net Margin

Net profit margin

31.7%24.9%LLY
ROE

Return on equity

97.9%32.8%LLY
ROA

Return on assets

18.3%12.1%LLY
ROIC

Return on invested capital

30.2%16.0%LLY

Growth

Compare revenue and earnings growth rates

LLY: 6NVS: 0
MetricLLYNVSWinner
Revenue Growth (YoY)

Year-over-year revenue growth

44.7%6.0%LLY
Revenue Growth (3Y)

3-year revenue CAGR

31.7%8.0%LLY
Revenue Growth (5Y)

5-year revenue CAGR

21.6%1.9%LLY
EPS Growth (YoY)

Year-over-year EPS growth

96.0%22.5%LLY
EPS Growth (3Y)

3-year EPS CAGR

51.7%31.4%LLY
EPS Growth (5Y)

5-year EPS CAGR

28.8%15.4%LLY

Balance Sheet & Risk

Compare financial stability and debt levels

LLY: 4NVS: 1
MetricLLYNVSWinner
Debt/Equity

Debt to equity ratio

1.600.80NVS
Current Ratio

Current assets to current liabilities

1.581.12LLY
Quick Ratio

Quick assets to current liabilities

1.190.89LLY
Interest Coverage

EBIT to interest expense

37.3415.13LLY
Beta

Stock volatility vs market

0.430.50LLY
Summary
LLY wins 3-1

Valuation

NVS

Profitability

LLY

Growth

LLY

Balance Sheet

LLY

NVS is more attractively valued. LLY shows stronger profitability. LLY demonstrates better growth. LLY has a stronger balance sheet.

Related Comparisons
Take Your Analysis Further

Dive deeper into LLY and NVS with Screenerhub. Access advanced screening tools, set up monitoring alerts, and discover more investment opportunities.

Embed This Comparison
Free

Add this comparison widget to your blog or website:

<a href="https://stockvs.app/LLY/vs/NVS" target="_blank" rel="noopener noreferrer" style="display: inline-flex; align-items: center; gap: 8px; padding: 8px 16px; background: linear-gradient(135deg, #3b82f6, #8b5cf6); color: white; text-decoration: none; border-radius: 8px; font-family: system-ui, sans-serif; font-size: 14px; font-weight: 500;">
  <svg width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M18 20V10"/><path d="M12 20V4"/><path d="M6 20v-6"/></svg>
  Compare LLY vs NVS on stockvs.app
</a>